StockWatch
·

Venmax Drugs And Pharmaceuticals Ltd Q3 FY26 Results

VENMAXQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue1.5517.7%680.0%
Total Income1.6222.9%714.4%
Expenditure1.5823.9%127.0%
PBT0.044.9%108.7%
Net Profit0.0332.1%106.5%
OPM-1.57%5.11pp
NPM1.98%0.14pp
EPS0.050.0%105.3%
View full financials

Informational and educational content only. Not investment advice.